DOI:
10.1055/s-00000062
Psychiatrische Praxis
LinksClose Window
References
Fu D-J, Ionescu DF, Li X. et al.
Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I).
J Clin Psychiatry 2020;
81: 19m13191
Access:
We do not assume any responsibility for the contents of the web pages of other providers.